Document is current

Article History

Received: 12 November 2024

Accepted: 24 March 2025

First Online: 23 April 2025

Declarations

:

: Mary Rensel has received research funding from Biogen, the CBJ Foundation, Genentech, NMSS, and PPD as well as patient education funding from Genzyme. She has served on the Data and Safety Monitoring Committee for Biogen and has acted as a speaker/consultant for EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, as well as for Genentech, Genzyme, Horizon, Improve Consulting, Kijia, MSAA, Novartis, and TG Therapeutics. She is also the founder of Brain Fresh. Amy B. Sullivan is a speaker/consultant for Amgen, Biogen, EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, Genentech, MSAA, and Novartis.

: This non-interventional survey received an Institutional Review Board exemption from the WCG IRB Affairs Department, Puyallup, Washington, USA, as it was a quantitative research study conducted with adult respondents. The study was conducted in accordance with international market research guidelines, and all data were securely stored in compliance with the General Data Protection Regulation, access-controlled, and anonymized. The participants provided their consent to participate in the survey and have their data published.